CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (8,363,676)	$ (1,658,155)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	685,954	956,027
Impairment loss on goodwill and other intangible assets	5,598,021
Impairment loss on property and equipment	800,000
Professional fee expenses payable with equity, including amortization of deferred expenses for prior period issuances	63,179	155,398
Compensation expenses payable with common shares and other equity	209,515	575,613
Amortization of discount on convertible debentures	540,651	523,268
Amortization of discount on notes payable	174,535	511,843
Debt extinguishment loss		132,427
Gain on litigation settlement		(743,943)
Bad debt expense and other	195,372	76,787
Net cash (used in) provided by operating activities, before changes in current assets and liabilities other than cash	(96,449)	529,265
Changes in current assets and liabilities other than cash:
(Increase) decrease in accounts receivable	(49,865)	16,338
Decrease (increase) in prepaid expenses	36,184	(17,213)
(Increase) decrease in inventories and other current assets	(9,772)	67,071
Increase (decrease) in accounts payable, accrued liabilities and amounts due to directors and officers	413,628	(62,898)
Increase (decrease) in deferred revenue	49,596	(75,071)
Net cash provided by operating activities	343,322	457,492
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment	(320,095)	(556,266)
Net cash (used in) investing activities	(320,095)	(556,266)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of ownership interest in Variable Interest Entity, net of expenses	885,392
Proceeds from notes payable, net of expenses	263,185	1,559,778
Proceeds from convertible debentures, net of expenses	248,783	489,508
Distributions to owners of Variable Interest Entity	(233,333)
Repayment of notes and leases payable	(663,637)	(1,566,553)
Repayment of convertible debentures	(595,745)	(251,962)
Net cash (used in) provided by financing activities	(95,355)	230,771
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(72,128)	131,997
CASH AND CASH EQUIVALENTS, beginning of year	389,015	257,018
CASH AND CASH EQUIVALENTS, end of year	316,887	389,015
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash payments for interest	935,293	1,055,268
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common shares for consultant services	113,600	150,521
Issuance of common shares for employee services	48,750	97,500
Issuance of common shares for interest and financing fees	34,700	393,080
Agreement to repurchase common shares	(11,429)	103,833
Issuance of New Sigma Note upon cancellation of Sigma Notes 1 and 2	$ 1,358,000